Skip to content

Durolane 1082020

by Bioventus LLC

Durolane 1082020 is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Bioventus LLC, approved under FDA PMA P170007 on 29 Aug 2017 and listed in FDA GUDID since 20 Nov 2017 (UDI-DI 00816986020808), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P170007

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00816986020808 UDI-DI Date20 Nov 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP170007 Date29 Aug 2017DecidedStatusActive

Official records

From the FDA record

Device description
DUROLANE is a clear, transparent, viscous gel of highly purified, stabilized, non-animal-derived sodium hyaluronate that is biosynthesized using bacterial fermentation. NASHA® technology is used to stabilize naturally entangled hyaluronic acid (HA) chains to produce a gel. The gel is suspended in phosphate- buffered saline at a concentration of 20 mg/mL. DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA PMA P170007 decided 29 Aug 2017 Active
  • FDA GUDID UDI-DI 00816986020808 listed 20 Nov 2017 Listed

Timeline

2 dated events

  1. Approved FDA PMA P170007
  2. Listed FDA GUDID 00816986020808

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Durolane
Generic name
Synovial fluid supplementation medium
Model / Ref / Catalog
1082020
Primary DI / UDI-DI
00816986020808
PMA number
FDA product code
MOZ
GMDN term
Synovial fluid supplementation medium
Device class
Class III
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).

Other devices from Bioventus LLC

See all devices from Bioventus LLC →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)